Loading...
XSHG
600529
Market cap1.89bUSD
Dec 05, Last price  
20.15CNY
1D
0.95%
1Q
-9.11%
Jan 2017
85.71%
IPO
573.91%
Name

Shandong Pharmaceutical Glass Co.

Chart & Performance

D1W1MN
XSHG:600529 chart
P/E
14.18
P/S
2.61
EPS
1.42
Div Yield, %
3.47%
Shrs. gr., 5y
2.22%
Rev. gr., 5y
11.36%
Revenues
5.13b
+2.87%
672,138,979826,714,2321,012,129,7571,158,292,0671,242,158,5221,513,418,3071,397,177,9951,468,092,8311,544,544,9521,691,112,4561,723,207,1652,057,473,0592,330,488,3512,584,627,1612,992,346,7513,427,069,4723,875,304,6634,187,279,2794,982,198,1675,125,270,640
Net income
943m
+21.55%
82,484,07694,055,248111,013,512141,991,489144,361,875171,330,127132,532,983119,828,142122,333,707124,702,667145,407,381189,604,926262,758,070358,209,968458,687,262564,439,557591,088,499618,287,086775,802,014942,991,305
CFO
1.17b
+11.17%
44,086,95378,468,091122,632,73591,758,958249,269,436217,011,545274,626,29128,519,302268,597,934266,634,293389,634,256506,528,107411,962,940465,773,178599,051,285566,009,160750,440,353252,442,3241,047,982,9691,165,050,367
Dividend
Oct 11, 20240.3 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Shandong Pharmaceutical Glass Co., Ltd manufactures and sells pharmaceutical glass packaging and butyl rubber series products in China. It offers pharma glass packaging products, such as molded injection glass vials, food-grade bottles, clear cosmetic bottles, cobalt blue and green bottles, tubular glass vials, ampoules, glass tubing products, amber glass bottles, and other borosilicate glass products; butyl rubber stoppers; prefilled syringes, plastic and aluminum caps, plastic caps, and plastic bottles; and dropper caps and Teflon coated rubber stoppers. The company sells its products to the pharmaceutical, food, and cosmetic glass packaging industries. It also exports its products to Europe, the United States, Russia, Japan, Korea, Southeast Asia, and other countries. Shandong Pharmaceutical Glass Co., Ltd was founded in 1970 and is based in Zibo, China.
IPO date
Jun 03, 2002
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT